-
公开(公告)号:US20130237578A1
公开(公告)日:2013-09-12
申请号:US13795768
申请日:2013-03-12
Applicant: EISAI R&D MANAGEMENT CO., LTD.
Inventor: Mark Spyvee , Takashi Sataoh , Jonathan Eric Carlson
IPC: C07D231/20
CPC classification number: C07D231/22 , C07D231/20
Abstract: The present invention provides compounds of Formula I: along with pharmaceutical compositions containing the same, and methods of use thereof in subjects in need of treatment.
Abstract translation: 本发明提供式I化合物以及含有其的药物组合物及其在需要治疗的受试者中的使用方法。
-
公开(公告)号:US20140155452A1
公开(公告)日:2014-06-05
申请号:US14173170
申请日:2014-02-05
Applicant: Eisai R&D Management Co., Ltd.
Inventor: Mark Spyvee , Takashi Satoh , Jonathan Eric Carlson
IPC: C07D231/22
CPC classification number: C07D231/22 , C07D231/20
Abstract: The present invention provides compounds of Formula I: along with pharmaceutical compositions containing the same, and methods of use thereof in subjects in need of treatment.
Abstract translation: 本发明提供式I化合物以及含有其的药物组合物及其在需要治疗的受试者中的使用方法。
-
公开(公告)号:US09000024B2
公开(公告)日:2015-04-07
申请号:US14173170
申请日:2014-02-05
Applicant: Eisai R&D Management Co., Ltd.
Inventor: Mark Spyvee , Takashi Satoh , Jonathan Eric Carlson
IPC: C07D231/22 , C07D231/20
CPC classification number: C07D231/22 , C07D231/20
Abstract: The present invention provides compounds of Formula I: along with pharmaceutical compositions containing the same, and methods of use thereof in subjects in need of treatment.
Abstract translation: 本发明提供式I化合物以及含有其的药物组合物及其在需要治疗的受试者中的使用方法。
-
公开(公告)号:US08686018B2
公开(公告)日:2014-04-01
申请号:US13795768
申请日:2013-03-12
Applicant: Eisai R&D Management Co., Ltd.
Inventor: Mark Spyvee , Takashi Satoh , Jonathan Eric Carlson
IPC: A61K31/415 , C07D231/20 , A61P29/00
CPC classification number: C07D231/22 , C07D231/20
Abstract: The present invention provides compounds of Formula I: along with pharmaceutical compositions containing the same, and methods of use thereof in subjects in need of treatment.
Abstract translation: 本发明提供式I化合物以及含有其的药物组合物及其在需要治疗的受试者中的使用方法。
-
-
-